Zimmer Biomet Holdings, Inc. (NYSE: ZBH) announced the completion of its previously disclosed issuance of $1.75 billion in senior notes. The offering includes $600 million of 4.700% notes due 2027, $550 million of 5.050% notes due 2030, and $600 million of 5.500% notes due 2035. The proceeds from this issuance will support the company's financial strategy and general corporate purposes.

The notes were issued under a supplemental indenture dated February 19, 2025, as part of Zimmer Biomet’s existing indenture agreement. Interest payments will be made semi-annually, with redemption provisions allowing the company to repurchase the notes before maturity under specific conditions.

Additionally, Zimmer Biomet reaffirmed its planned acquisition of Paragon 28, Inc. If the merger is not completed by the specified deadline, the company will be required to redeem the 2030 and 2035 notes at a special mandatory redemption price of 101% of their principal amount, plus accrued interest.

This financing move aligns with Zimmer Biomet’s long-term growth strategy as it continues to expand its portfolio and strengthen its financial position.